Cornelis J.M. Melief

Author

Also Known As

C J M Melief, C J Melief, C. J. M. Melief, C. J. Melief, C. Melief, C.J. Melief, C.J.M Melief, C.J.M. Melief, CORNELIS J. M. MELIEF, Cornelis J M Melief

368

Publications

32K

Citations

H-Index

102

Concepts

All Affiliations

Leiden University Medical Center Leiden University ISA Pharmaceuticals (Netherlands)The Netherlands Cancer Institute University of Amsterdam

About

Cornelis J.M. Melief is an author at Leiden University Medical Center specializing in immunology, medicine, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	47	86	8.7K
2	Allergy	15	17	2K
3	Natural Sciences	3	3	200
4	Public Health	2	2	99
5	Health Sciences	1	1	24

Cornelis J.M. Melief

188

Publications

22.5K

Citations

H-Index

Page 1

	Year	Citations
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens Matthew M. Gubin, Xiuli Zhang, Heiko Schuster, Nature	2014	2K
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity José Mayordomo, Tatiana Zorina, Walter J. Storkus, Nature Medicine Marrow-derived Dendritic CellsTumor ImmunologyTherapeutic Antitumour ImmunityImmunologyTumor Immunity	1995	1.1K
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia Gemma G. Kenter, Marij J.P. Welters, A. Rob P.M. Valentijn, New England Journal of Medicine	2009	1.1K
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells Mariet C.W. Feltkamp, Henk L. Smits, Michel Vierboom, European Journal of Immunology	1993	834
Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors Ferry Ossendorp, Erica Mengedé, Marcel Camps, The Journal of Experimental Medicine Cytotoxic T LymphocytesClass IiT-regulatory CellImmunologyPathology	1998	600
Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients Jasper G. van den Boorn, Debby Konijnenberg, Trees A. M. Dellemijn, Journal of Investigative Dermatology InflammationAutoimmune DiseaseMedicineMelanomaImmunology	2009	510
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy Linda Diehl, Annemieke Th. den Boer, Stephen P. Schoenberger, Nature Medicine Tumor ImmunologyAutoimmune DiseaseAllergyImmunologyAntigen Processing	1999	457
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related Cancer Erminia Massarelli, William William, Faye M. Johnson, JAMA Oncology	2018	449
High Number of Intraepithelial CD8+ Tumor-Infiltrating Lymphocytes Is Associated with the Absence of Lymph Node Metastases in Patients with Large Early-Stage Cervical Cancer Sytse J. Piersma, Ekaterina S. Jordanova, Mariëtte I.E. van Poelgeest, Cancer Research	2007	416
Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides Sander Zwaveling, Sandra C. Ferreira Mota, Jan Nouta, The Journal of Immunology ImmunologyPathologyAntigen ProcessingCd4 T Cell ResponsesImmunotherapy	2002	413

Page 1